The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Johnson & Johnson
Potential drug-drug interaction events in patients treated with abiraterone acetate plus prednisone or enzalutamide.
 
Dominic Pilon
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst)
 
Ajay S. Behl
No Relationships to Disclose
 
Bruno Emond
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen Scientific Affairs (Inst); Regeneron (Inst)
 
Yongling Xiao
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Medtronic (Inst); Novartis (Inst)
 
Patrick Lefebvre
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Medtronic (Inst); Novartis (Inst); Noven (Inst); Novo Nordisk (Inst)
 
Christopher J. Kane
Stock and Other Ownership Interests - SNP Bio
Honoraria - Johnson & Johnson
Consulting or Advisory Role - Tokai Pharmaceuticals
Speakers' Bureau - Johnson & Johnson
Research Funding - GenomeDx